The Valley Desk

ArticleFrontiers in pharmacologyPublished

Investigating therapeutic response to netarsudil in glaucoma subjects with the ARHGEF12 risk variant

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Frontiers in pharmacology
Published
Subject terms
neuroprotection; Primary Open-angle Glaucoma; Rho/rock Pathway; Rho Kinase (Rock) Inhibitor; Arhgef12; Netarsudil; Rhopressa
PubMed ID
42181883
PubMed Central ID
PMC13194400
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal